HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
Pomalidomide
Description
Pomalidomide, an analogue of thalidomide, is an immunomodulatory antineoplastic agent. FDA approved on February 8, 2013.
Company not known
Imnovid
